US Patent Issued to PTC Therapeutics MP on May 26 for "Pharmaceutically acceptable salts of sepiapterin" (American, Japanese Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,637,465, issued on May 26, was assigned to PTC Therapeutics MP Inc. (Warren, N.J.).

"Pharmaceutically acceptable salts of sepiapterin" was invented by Daniel E. Levy (San Mateo, Calif.), Neil Smith (Cary, N.C.), Jonathan Reis (Brookline, Mass.), Hiroshi Yoshino (Narashino, Japan), Taichi Komoda (Narashino, Japan), Yuichi Shiro (Narashino, Japan), Shunichi Murata (Narashino, Japan), Takayoshi Matsumoto (Narashino, Japan) and Kaito Kishimoto (Narashino, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to new pharmaceutical salts and/or co-crystals of sepiapterin which exhibit improved properties. In particular, the inventi...